when fda approve compass pathways comp360 psilocybin

    Before Mar 1, 2027

    when fda approve compass pathways comp360 psilocybin. Best Yes near 63¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 63¢ · Best No: 45¢ · 1 platform

    • Kalshi: Yes 63¢ / No 45¢
    TRADING OPEN

    Before Mar 1, 2027

    Volume

    $2.0K

    $15 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jun 30, 2027

    ~289 days left

    Category

    Culture

    63¢CHANCE OF YES58%42%
    Yes
    63¢
    Kalshi
    No
    45¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    kalshi
    Kalshi
    Best Yes
    Best No
    Yes
    63¢
    No
    45¢
    Vol
    $2.0K
    $15 24h
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 63¢: exit costs ~1.63¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jun 30, 2027
    Time Left289 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In